A functional
RNase P ribozyme (M1GS
RNA) was constructed to target the overlapping
mRNA region of two murine cytomegalovirus (MCMV)
capsid proteins essential for viral replication: the assembly
protein (mAP) and M80. The customized
ribozyme efficiently cleaved the target
mRNA sequence in vitro. Moreover, 80% reduction in the expression of mAP and M80 and a 2,000-fold reduction in viral growth were observed in cells expressing the
ribozyme. In contrast, there was no significant reduction in viral gene expression and growth in cells that either did not express the
ribozyme or produced a "disabled"
ribozyme carrying mutations that abolished its catalytic activity. When the
ribozyme-expressing constructs were delivered into MCMV-infected SCID mice via a modified "hydrodynamic transfection" procedure, expression of
ribozymes was observed in the livers and spleens. Compared with the control animals that did not receive any M1GS constructs or received the disabled
ribozyme construct, animals receiving the functional
ribozyme construct exhibited a significant reduction of viral gene expression and
infection. Viral titers in the spleens, livers, lungs, and salivary glands of the functional
ribozyme-treated SCID mice at 21 days after
infection were 200- to 2,000-fold lower than those in the control animals. Moreover, survival of the infected animals significantly improved upon receiving the functional
ribozyme construct. Our study examines the use of M1GS
ribozymes for inhibition of gene expression in animals and demonstrates the utility of
RNase P ribozymes for gene targeting applications in vivo.